Inventor · disambiguated record
Colin M. Tice
Also filed as: TICE COLIN · TICE COLIN M · TICE COLIN MICHAEL
90 granted patents·23 pending applications·809 citations·filing 1990–2024
99Inventor score
Files withVITAE PHARMACEUTICALS INC22ROHM & HAAS21CLAREMON DAVID A19BALDWIN JOHN J13VITAE PHARMACEUTICALS LLC12
Top patents by PatentIndex Score
113 records- 0196US5300477A2-arylpyrimidines and herbicidal use thereofROHM & HAAS·Filed 1993·Granted Apr 5, 1994·93 cites·13 claims
- 0295US9663515B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·13 cites·15 claims
- 0395US8242111B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Aug 14, 2012·36 cites·24 claims
- 0495US8138178B2Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Mar 20, 2012·37 cites·24 claims
- 0595US7456315B2Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexINTREXON CORP·Filed 2004·Granted Nov 25, 2008·67 cites·4 claims
- 0694US10047085B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2017·Granted Aug 14, 2018·14 cites·20 claims
- 0794US9624217B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Apr 18, 2017·14 cites·22 claims
- 0894US7563928B2Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexINTREXON CORP·Filed 2007·Granted Jul 21, 2009·23 cites·2 claims
- 0994US7304161B2Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complexINTREXON CORP·Filed 2004·Granted Dec 4, 2007·38 cites·5 claims
- 1093US10399976B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2018·Granted Sep 3, 2019·11 cites·20 claims
- 1193US9868748B2Thiazolopyrrolidine inhibitors of ROR- γVITAE PHARMACEUTICALS INC·Filed 2014·Granted Jan 16, 2018·13 cites·19 claims
- 1293US9796710B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Oct 24, 2017·12 cites·14 claims
- 1392US10087184B2Dihydropyrrolopyridine inhibitors of RORγVITAE PHARMACEUTICALS INC·Filed 2017·Granted Oct 2, 2018·10 cites·13 claims
- 1492US8202857B21,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Jun 19, 2012·21 cites·75 claims
- 1592US7851220B2Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complexINTREXON CORP·Filed 2007·Granted Dec 14, 2010·14 cites·6 claims
- 1692US5393735AHerbicidal glutarimidesROHM & HAAS·Filed 1993·Granted Feb 28, 1995·45 cites·15 claims
- 1791US8748125B2Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complexHORMANN ROBERT EUGENE·Filed 2007·Granted Jun 10, 2014·9 cites·16 claims
- 1891US8440658B2Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2008·Granted May 14, 2013·16 cites·19 claims
- 1990US8524948B2Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexHORMANN ROBERT EUGENE·Filed 2011·Granted Sep 3, 2013·10 cites·2 claims
- 2090US5631209AHerbicidal glutarimidesROHM & HAAS·Filed 1995·Granted May 20, 1997·45 cites·20 claims
- 2190US5502027AHerbicidal glutarimidesROHM & HAAS·Filed 1994·Granted Mar 26, 1996·43 cites·20 claims
- 2289US7858624B2Piperidine and morpholine renin inhibitorsVITAE PHARMACEUTICALS INC·Filed 2007·Granted Dec 28, 2010·7 cites·4 claims
- 2389US7754737B2Diaminoalkane aspartic protease inhibitorsVITAE PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·16 cites·10 claims
- 2488US10301261B2Substituted indoles as modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2016·Granted May 28, 2019·6 cites·22 claims
- 2588US7872028B2Diaminopropanol renin inhibitorsVITAE PHARMACEUTICALS INC·Filed 2007·Granted Jan 18, 2011·14 cites·10 claims
- 2687US10807980B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Oct 20, 2020·4 cites·20 claims
- 2786US11535614B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Dec 27, 2022·1 cites·20 claims
- 2886US9416135B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2015·Granted Aug 16, 2016·4 cites·27 claims
- 2986US9272986B2Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complexINTREXON CORP·Filed 2014·Granted Mar 1, 2016·7 cites·19 claims
- 3084US9006244B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2013·Granted Apr 14, 2015·5 cites·49 claims
- 3184US5866513AAryl-substituted cycloalkanes and cycloalkenes and herbicidal use thereofROHM & HAAS·Filed 1997·Granted Feb 2, 1999·25 cites·11 claims
- 3283US8575156B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2008·Granted Nov 5, 2013·5 cites·20 claims
- 3382US10829448B2Substituted benzoimidazoles as modulators of ROR-γVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Nov 10, 2020·1 cites·6 claims
- 3482US8569292B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Oct 29, 2013·5 cites·7 claims
- 3581US9102648B1Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexHORMANN ROBERT EUGENE·Filed 2007·Granted Aug 11, 2015·3 cites·28 claims
- 3680US9845308B2Isoindoline inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted Dec 19, 2017·2 cites·12 claims
- 3780US9169210B2Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexHORMANN ROBERT EUGENE·Filed 2012·Granted Oct 27, 2015·3 cites·3 claims
- 3880US8598160B2Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Dec 3, 2013·4 cites·15 claims
- 3980US8592410B2Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Nov 26, 2013·4 cites·10 claims
- 4080US7375093B2Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complexINTREXON CORP·Filed 2003·Granted May 20, 2008·8 cites·12 claims
- 4179US11001583B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted May 11, 2021·1 cites·11 claims
- 4279US9359289B2Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexINTREXON CORP·Filed 2013·Granted Jun 7, 2016·2 cites·9 claims
- 4379US8198453B2Piperidine renin inhibitorsBALDWIN JOHN J·Filed 2007·Granted Jun 12, 2012·3 cites·3 claims
- 4478US9255273B2Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complexHORMANN ROBERT EUGENE·Filed 2012·Granted Feb 9, 2016·2 cites·2 claims
- 4578US8680281B2Lactam inhibitors of 11-β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Mar 25, 2014·3 cites·15 claims
- 4678US8383629B2Inhibitors of 11β-hydroxysteroid dehydrogenase type 1VITAE PHARMACEUTICALS INC·Filed 2009·Granted Feb 26, 2013·3 cites·27 claims
- 4777US10829481B2Benzimidazole derivatives as modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Nov 10, 2020·1 cites·22 claims
- 4877US8673899B2Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2012·Granted Mar 18, 2014·3 cites·22 claims
- 4976US8598163B2Derivatives of [1,3]Oxazin-2-one useful for the treatment of metabolic diseases such as lipid disordersCLAREMON DAVID·Filed 2010·Granted Dec 3, 2013·6 cites·30 claims
- 5075US9707232B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2016·Granted Jul 18, 2017·1 cites·19 claims
Showing the top 50 of 113 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Colin M. Tice files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →